ストックスクリーナーアプリを入手
37.08
2.29%
-0.845
Beam Therapeutics Inc (BEAM) 最新ニュース
Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration; Shares Rise - marketscreener.com
Prime Medicine Secures Favorable Arbitration Ruling in Beam Therapeutics Case - Benzinga
BofA reiterates Beam Therapeutics stock rating after arbitration ruling - Investing.com
Prime Medicine stock surges after winning arbitration with Beam By Investing.com - Investing.com South Africa
Why is Beam Therapeutics stock sliding today? By Investing.com - Investing.com Canada
Prime Medicine gains after winning arbitration with Beam Therapeutics - Seeking Alpha
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics - The Manila Times
Prime Medicine clears Beam dispute, keeps PM647 for AATD - Stock Titan
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal - Yahoo Finance
H.C. Wainwright reiterates Beam Therapeutics stock rating on BLA progress - Investing.com
Russell Value Index Additions Could Be A Game Changer For Beam Therapeutics (BEAM) - simplywall.st
Beam Therapeutics stock hits 52-week high at 36.89 USD - Investing.com
Beam Therapeutics stock hits 52-week high at 36.89 USD By Investing.com - Investing.com South Africa
Understanding the Setup: (BEAM) and Scalable Risk - Stock Traders Daily
Beam Therapeutics Inc. Stock 12‑Month Price Target Cut to $49.87, Implies 43% Upside - TradingView
FMR LLC Reduces Stake in Beam Therapeutics Inc. - GuruFocus
Beam Therapeutics (NASDAQ: BEAM) CMO sells 373 shares for tax withholding - Stock Titan
BEAMBeam Therapeutics Inc Latest SEC Filings - Finviz
BEAM Stock Price, Quote & Chart - ChartMill
Beam Therapeutics (BEAM) CEO exercises options and sells 50K shares under plan - Stock Titan
BEAM Stock's Gains Fade Despite Promising Data Rare Liver Disease Treatment Data - Stocktwits
Form 144 BEAM THERAPEUTICS INC. For: 30 June By Investing.com - Investing.com Nigeria
Hedge Fund and Insider Trading News: Paul Singer, Warren Buffett, Ray Dalio, George Soros, Millennium Management, Point72 Asset Management, Citadel Investment Group, CG Oncology Inc (CGON), Beam Therapeutics Inc (BEAM), and More - Insider Monkey
BEAM News | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMill
Beam Therapeutics(BEAM.US) 10% Shareholder Sells US$10.04 Million in Common Stock - Moomoo
Form 144 BEAM THERAPEUTICS INC. For: 29 June By Investing.com - Investing.com South Africa
FMR LLC sells $10.04 million in Beam Therapeutics shares By Investing.com - Investing.com Australia
BEAM (NASDAQ: BEAM) insider files to sell 25,000 shares via option exercise - Stock Titan
Form 4 Beam Therapeutics Inc For: 29 June By Investing.com - Investing.com Nigeria
FMR LLC sells $10.04 million in Beam Therapeutics shares - Investing.com
FMR LLC (BEAM) trims Beam Therapeutics stake with 284,860-share open-market sale - Stock Titan
Beam Therapeutics Inc.(NasdaqGS: BEAM) added to Russell 2000 Value Benchmark - marketscreener.com
Beam Therapeutics Inc.(NasdaqGS: BEAM) added to Russell 3000E Value Benchmark - marketscreener.com
Beam Therapeutics Inc.(NasdaqGS:BEAM) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade) (NASDAQ:BEAM) - Seeking Alpha
Beam Therapeutics, Inc. Actuals & Estimates (NASDAQ:BEAM) - TradingView
BEAM Forecast — Price Target — Prediction for 2027 - TradingView
Beam Therapeutics, Inc. Actuals & Estimates (BMV:BEAM) - TradingView
Price to sales forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView
Enterprise value to EBIT forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView
Enterprise value to revenue forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView
Price to book forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView
Enterprise value to EBITDA forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView
Price to earnings forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView
Beam Therapeutics (BEAM) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
The Technical Signals Behind (BEAM) That Institutions Follow - Stock Traders Daily
Wedbush Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $65 - Moomoo
Beam Therapeutics stock soars 21% in three months: Here's why - MSN
Beam Therapeutics president exercises 35,505 options | BEAM Insider Trading - Stock Titan
Beam Therapeutics stock hits 52-week high at 36.66 USD By Investing.com - Investing.com Australia
Beam Therapeutics stock hits 52-week high at 36.66 USD - Investing.com
2.81%
0.03%
大文字化:
|
ボリューム (24 時間):